The buck stops ear: Hear­ing loss biotech to look for 's­trate­gic op­tion­s' as da­ta analy­ses prove fruit­less

A Cal­i­for­nia biotech fo­cused on de­vel­op­ing treat­ments for neu­ro­log­i­cal con­di­tions of the ear ap­pears to be think­ing about clos­ing up shop.

San Diego-based Oton­o­my said …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER